
SS Innovations International Inc.: stock overview
Price
$1.66
November 13, 2026Market cap $332M
What Ploutos Investor adds for SS Innovations International
Part of Ploutos Investor, €9.99 a month
- The full history: 4 fiscal years, from 2022
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 57% since Aug 13, 2026, when the 10-Q these figures come from was filed ($3.83 then, $1.66 on Nov 13, 2026). The figures date from before that move.10-Q
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
In short
SS Innovations International had revenue of $52M over the last 12 months and a net loss of $12M. Revenue fell by 69.1% a year on average over the last 3 years. It pays no dividend.
From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $332M
- 200M shares
- P/E
- –
- Revenue, 12 months
- $52M
- -69.1% a year over 3 years
- Net margin
- -23.7%
- 2025: -28.5%, above 21% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
-91.5% a year over 2 years
Fiscal years in figures
SSII's revenue, profit, cash flow and dividend with each year-end price, from 2022 to 2022, 1 more fiscal year
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 4 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap
- $332M
- Enterprise value
- –
- P/E
- –
- EV / EBIT
- –
- EV / Revenue
- –
- P/B
- 6.2
- FCF yield
- –
- Earnings yield
- –
Profitability
- Gross margin
- 47.7%
- Operating margin
- -15.8%
- Net margin 3-year median: -28.5%
- -23.7%
- ROIC
- -14.3%
- ROIC, 5-year average
- -55.2%
- ROE
- -27.3%
Growth
- Revenue, yearly change
- +105.7%
- EPS, yearly change
- –
- FCF, yearly change
- –
- Revenue, average a year
- -69.1%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $14M
- Total debt
- –
- Net cash
- –
- Net debt / EBITDA
- –
- Interest cover
- -28.7x
- Current ratio
- 2.24
Balance sheet of June 30, 2026.
Returns to shareholders
- Dividend yield
- 0.00%
- Buybacks
- –
- Total returned
- 0.00%
- Shares, yearly change
- +3.5%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).
Gross margin
46.0%
Above 28% of the 161 companies in its industry, and 64% of all.
Operating margin
-19.3%
Above 24% of the 186 companies in its industry, and 15% of all.
Net margin
-28.5%
Above 21% of the 189 companies in its industry, and 11% of all.
ROE
-31.7%
Above 20% of the 174 companies in its industry, and 10% of all.
ROA
-16.3%
Above 23% of the 190 companies in its industry, and 11% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- SS Innovations International, Inc.
- CIK
- 1676163
- Exchange
- NASDAQ
- Industry (SIC)
- 3841 · Surgical & Medical Instruments & Apparatus
- Fiscal year ends
- December 31
- Latest annual report
- December 31, 2025
- Reporting currency
- USD
- Shares
- 200M
Other companies: Healthcare
The largest companies of the same sector, each with its own page.
- LLYEli Lilly and Company+0,00%Compare with SSII
- JNJJohnson & Johnson+0,00%Compare with SSII
- ABBVAbbVie+0,00%Compare with SSII
- UNHUnitedHealth+0,00%Compare with SSII
- MRKMerck & Company+0,00%Compare with SSII
- AMGNAmgen+0,00%Compare with SSII
- TMOThermo Fisher Scientific+0,00%Compare with SSII
- ABTAbbott Laboratories+0,00%Compare with SSII
The full analysis
What do SS Innovations International's filings show?
These are SS Innovations International's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is SSII's market cap?
SS Innovations International Inc.'s market cap is $332M, at a price of $1.66 on November 13, 2026 and 200M shares.
How much revenue does SSII have?
SS Innovations International had revenue of $52M over the last 12 months. Over the last 3 years it changed by -69.1% a year on average.
Does SSII pay a dividend?
No. SS Innovations International paid no regular dividend over the last 12 months.
Where do the figures come from?
From SS Innovations International Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.